Led by Dr. Shawn M. Cole, Founder of Celly Health, has over 200+ combined peer-reviewed publications across medical leaders. Celly Health's Traverse City Innovation Center drives research in value-based care, chronic inflammation and Long COVID protocols.
Pioneering blood-based biomarker panels and targeted treatment approaches for post-infectious disease. Our protocols have been refined through thousands of patient outcomes at the Innovation Center.
Identifying novel inflammatory markers for earlier diagnosis and more targeted interventions. Working to establish standardized panels that can be deployed across our national network.
Measuring clinical outcomes across our 7-hub network to improve care quality and reduce costs. Building the data infrastructure to demonstrate superior patient outcomes at scale.
Researching predictive factors for GLP-1 medication response to personalize weight management protocols. Combining metabolic testing with treatment data to optimize dosing and outcomes.
We partner with research institutions, labs, and health systems on clinical studies.